Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion

Week in Review: Hansoh Signs $456 Million Deal for siRNA Products

Week in Review: MicroTech Medical Staging $245 Million HK IPO for Diabetes Products

Week in Review: Innovent Acquires Novel Atopic Dermatitis Treatment in $267 Million Pact

Week in Review: Broncus Stages $200 Million Hong Kong IPO for Pulmonary Devices

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China